Letter to the editor.
Faculty of Health Sciences, University of Ottawa , Ottawa, ON , Canada.
Eric
E
Druyts
Kristian
K
Thorlund
Edward J
EJ
Mills
D000998:Antiviral Agents / Q000191:economics*; D004359:Drug Therapy, Combination / Q000191:economics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000191:economics*; D009842:Oligopeptides / Q000191:economics*; D011092:Polyethylene Glycols / Q000191:economics*; D011392:Proline / Q000031:analogs & derivatives*; D012254:Ribavirin / Q000191:economics*
D000998:Antiviral Agents; D016898:Interferon-alpha; D009842:Oligopeptides; D011092:Polyethylene Glycols; D012254:Ribavirin; D011392:Proline